GLP-1s are intended to be taken long-term to fully achieve their benefits
For those who are ready for a smarter approach
Treatment Goals and Timeline Your specific goals matter
AOD 9604: Chemical Identity AOD 9604 is a synthetic growth hormonederived peptide fragment corresponding to the C-terminal lipolytic region of human GH, with an additional N-terminal tyrosine residue incorporated to improve structural stability in laboratory systems
For example, one study found that hyperbaric oxygen treatments can raise oxidative stress
Product Specialization : Tablets Capsules, Liquid Injection, Lyophilized Injection, Dry Powder Injection, Oral Liquids, External Preparation ( Cream/Ointment/Jelly), Prefilled Syringe (PFS), Suppositories, Cytotoxic drugs (Oncology), Small Volume Parenterals (SVP), Soft Gelatin